|
Volumn 252, Issue 2, 2009, Pages 319-321
|
Science to practice: How do we interpret the transfer of hyperpolarized 129Xe from blood into alveolar gas?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CONTRAST MEDIUM;
UNCLASSIFIED DRUG;
XENON;
XENON 129;
DIAGNOSTIC AGENT;
ABSENCE OF SIDE EFFECTS;
BLOOD;
COMPUTER ASSISTED TOMOGRAPHY;
CONTRAST ENHANCEMENT;
DRUG SAFETY;
DRUG SOLUBILITY;
HUMAN;
HYPERPOLARIZATION;
IMAGING SYSTEM;
LUNG ALVEOLUS;
LUNG GAS EXCHANGE;
LUNG VENTILATION PERFUSION RATIO;
NON INVASIVE PROCEDURE;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
SHORT SURVEY;
CLINICAL PRACTICE;
COMPUTER ASSISTED DIAGNOSIS;
INHALATIONAL DRUG ADMINISTRATION;
LUNG CIRCULATION;
METHODOLOGY;
NOTE;
PHYSIOLOGY;
SCIENCE;
TECHNOLOGY;
ADMINISTRATION, INHALATION;
CONTRAST MEDIA;
IMAGE INTERPRETATION, COMPUTER-ASSISTED;
MAGNETIC RESONANCE IMAGING;
PHYSICIAN'S PRACTICE PATTERNS;
PULMONARY ALVEOLI;
PULMONARY CIRCULATION;
PULMONARY GAS EXCHANGE;
SCIENCE;
TECHNOLOGY TRANSFER;
XENON ISOTOPES;
|
EID: 70249133693
PISSN: 00338419
EISSN: 15271315
Source Type: Journal
DOI: 10.1148/radiol.2522090555 Document Type: Short Survey |
Times cited : (4)
|
References (7)
|